Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2296930 | 0.87 | TSHR (0.34) | TSHRGLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL26628998 | 0.82 | CYP2D6 (0.33) | TSHRGLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL8306704 | 0.78 | — | — | |
| SCHEMBL2346338 | 0.78 | — | — | |
| SCHEMBL79140 | 0.78 | — | — | |
| SCHEMBL2289378 | 0.77 | TSHR (0.59) | TSHRGLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL6062547 | 0.76 | TSHR (0.57) | TSHRALDH1A1HSD17B10CYP2D6CYP2C19 | |
| SCHEMBL5390019 | 0.76 | GLO1 (0.50) | TSHRGLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL5390016 | 0.76 | GLO1 (0.50) | TSHRGLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL10539079 | 0.76 | GLO1 (0.50) | TSHRGLO1ALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023215886-A1 | ENGINEERED PARTICLES AS RED BLOOD CELL MIMICS AND COMPOSITIONS CONTAINING SAME FOR HEMATOLOGY | SLINGSHOT BIOSCIENCES, INC. (US) | 2023-11-09 | — | — | WO | claimed |
| EP-2349459-A1 | TREATMENT OF SWEATING AND HYPERHIDROSIS | Johnson & Johnson Consumer Companies, Inc. (US) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010027792-A1 | TREATMENT OF SWEATING AND HYPERHIDROSIS | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2010-03-11 | — | — | WO | disclosed |